Fundraising Fox

Martin Babler

President, Chief Executive Officer and Chairman of the Board at Alumis

San Francisco, California, United States

President, Chief Executive Officer and Chairman of the Board at Alumis

Intro paths

→

In turn, Martin can intro founders to Alumis's investors below.

Alumis's investors · 8

Foresite CapitalWest Hollywood · since 2024Nextech InvestZurich · $648K – $3.2M checksOrbiMedNew York · $1M – $75M checksSamsara BioCapitalPalo AltoSR One Capital ManagementRedwood CityvenBio Global StrategicSan Francisco · since 2024venBio PartnersSan FranciscoWestlake Village BioPartnersLos Angeles · $100K – $5M checks

Experience

  1. AlumisChairman, President and CEOcurrent2021 — presentSan Francisco Bay Area
  2. Prelude TherapeuticsBoard Membercurrent2021 — presentWilmington, Delaware, United States
  3. Paradigm Ranch Management LLCCo-Ownercurrent2008 — presentSonoma County, California, United States
  4. 89bioBoard Member2024 — 2025
  5. Sardona TherapeuticsChairman of the Board2021 — 2025San Francisco Bay Area
  6. Omega Alpha SPACBoard Member2021 — 2024Boston, Massachusetts, United States
  7. Neoleukin TherapeuticsBoard Member2020 — 2023
  8. Principia BiopharmaPresident and CEO2011 — 2020
  9. ZS Pharma, Inc.Board Member2015
  10. Talima TherapeuticsPresident and CEO2007 — 2011
  11. MMABoardmember2005 — 2007
  12. GenentechVP Sales and Marketing Immunology2003 — 2006
  13. Genentechvarious1998 — 2002
  14. Eli Lilly and Companyvarious1992 — 1998

Skills & more

Drug DiscoveryPharmaceutical IndustryClinical DevelopmentHealthcareBiotechnologyOncologyPharmaceutical SalesManaged CareCardiologyImmunologyLifesciencesBiopharmaceuticals
+10 moreInfectious DiseasesCommercializationMedical DevicesStart-upsStrategic PlanningNeurologyDrug DevelopmentProduct LaunchCross-functional Team LeadershipMolecular Biology

From Martin's professional profile.

Frequently asked questions

Who is Martin Babler?
President, Chief Executive Officer and Chairman of the Board at Alumis
Where does Martin Babler work?
Martin Babler is President, Chief Executive Officer and Chairman of the Board at Alumis.

Are you in our directory? — or find your own page and tap it there to see your paths to every investor.

Founder mafias

Principia Biopharma mafia4

Also came through, then founded or led a company.

Peter ThompsonChairman of the BoardFounded Cleave Biosciences +2Peter Thompson, M.D.Chairman of the BoardFounded Cleave Biosciences +2Richard A. MillerFounder, President, CEO and DirectorFounded Corvuspharma

Shared employers

Also worked at Neoleukin Therapeutics1

Matthew BickExecutive Officer, Director, Promoter at Accipiter Biosciences

Also worked at Principia Biopharma5

Chris ChaiOperating Partner - Portfolio Capital Raising at SR One Capital ManagementMike DybbsPartner at Samsara BioCapitalPeter ThompsonGeneral Partner at OrbiMedPeter Thompson, M.D.Investor at OrbiMedRichard A. MillerPresident & CEO, Co-Founder at Corvuspharma

Also worked at Genentech172

David SchenkeinInvestor at GV (Google Ventures)Karthik ArdhanareeswaranInvestor at GV (Google Ventures)Marco PrunottoInvestor at MedicxiLogan HilleLife Sciences Analyst at CincyTechJosephine ChenInvestor at Sequoia CapitalAbbie CelnikerInvestor at Third Rock Ventures

+ 166 more

Also worked at Eli Lilly and Company117

David MollerInvestor at Third Rock VenturesJesper GromadaInvestor at Third Rock VenturesMark LevinRetired Founding Partner at Third Rock VenturesNatalie FurneyGlobal General Counsel at Takeda VenturesRhonda PachecoPresident, U.S. Business Unit and U.S. Country Head at Takeda VenturesCarlos PayaVenture Partner at Ysios Capital

+ 111 more